What should I sell?
| Company | Ticker |  Margin |
Valuation |
|---|---|---|---|
| Inhibitex, Inc. | INHX |
Overvalued by 98%
|
$0.35 |
| Echo Therapeutics Inc | ECTE |
Overvalued by 98%
|
$0.01 |
| Pharmasset, Inc. | VRUS |
Overvalued by 98%
|
$2.22 |
| PROLOR Biotech, Inc. | PBTH |
Overvalued by 97%
|
$0.53 |
| Burcon NutraScience Corporation | BU |
Overvalued by 97%
|
$0.08 |
| NPS Pharmaceuticals, Inc. | NPSP |
Overvalued by 97%
|
$1.35 |
| Idenix Pharmaceuticals, Inc. | IDIX |
Overvalued by 96%
|
$0.82 |
| bioasis Technologies Inc. | BTI |
Overvalued by 96%
|
$0.04 |
| Protox Therapeutics Inc. | PRX |
Overvalued by 96%
|
$0.10 |
| GeneNews Limited | GEN |
Overvalued by 96%
|
$0.01 |
| Helix Biopharma Corp. | HBP |
Overvalued by 95%
|
$0.08 |
| Daxor Corporation | DXR |
Overvalued by 95%
|
$0.39 |
| CYANOTECH CORP | CYAN |
Overvalued by 95%
|
$0.18 |
| PURE Bioscience | PURE |
Overvalued by 95%
|
$0.05 |
| ACADIA Pharmaceuticals Inc. | ACAD |
Overvalued by 94%
|
$1.80 |
| Neoprobe Corporation | NEOP |
Overvalued by 94%
|
$0.05 |
| Cepheid | CPHD |
Overvalued by 94%
|
$2.79 |
| Nanosonics Ltd. | NAN |
Overvalued by 94%
|
$0.19 |
| Synageva Biopharma Corp | GEVA |
Overvalued by 94%
|
$12.84 |
| Cardium Therapeutics Inc. | CXM |
Overvalued by 94%
|
$0.02 |
| InterMune, Inc. | ITMN |
Overvalued by 94%
|
$4.15 |
| Incyte Corporation | INCY |
Overvalued by 93%
|
$5.48 |
| AVI BioPharma, Inc. | AVII |
Overvalued by 93%
|
$3.65 |
| Narhex Life Sciences Limited | NLS |
Overvalued by 93%
|
$0.03 |
| WuXi PharmaTech (Cayman) Inc. (ADR) | WX |
Overvalued by 93%
|
$3.00 |